NCT07175935 Amyotrophic Lateral Sclerosis Registry in Thailand
| NCT ID | NCT07175935 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chulalongkorn University |
| Condition | ALS (Amyotrophic Lateral Sclerosis) |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-03-01 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-03-01 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a prospective, observational, multicenter registry designed to collect comprehensive clinical, genetic, and outcome data from patients diagnosed with amyotrophic lateral sclerosis (ALS) across Thailand. The registry will establish a national dataset to describe epidemiology, clinical presentation, progression, and treatment outcomes, and will serve as a platform for future clinical and translational research.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of ALS according to El Escorial or Gold Coast criteria * Age ≥ 18 years * Ability and willingness to provide informed consent Exclusion Criteria: * Patients unwilling to provide informed consent * Patients with alternative diagnoses mimicking ALS
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07175935 clinical trial?
This trial is open to participants of all sexes, studying ALS (Amyotrophic Lateral Sclerosis). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07175935 currently recruiting?
Yes, NCT07175935 is actively recruiting participants. Contact the research team at jakkrit.a@chula.ac.th for enrollment information.
Where is the NCT07175935 trial being conducted?
This trial is being conducted at Pathum Wan, Thailand.
Who is sponsoring the NCT07175935 clinical trial?
NCT07175935 is sponsored by Chulalongkorn University. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.